HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sedation and recovery of psychomotor function after intravenous administration of various doses of midazolam and diazepam.

Abstract
A placebo-controlled, double-blind, crossover trial in 11 healthy male volunteers compared clinical sedation and psychomotor function after intravenous injection of midazolam (0.05, 0.1, or 0.15 mg/kg), diazepam (0.15 or 0.3 mg/kg), or placebo (saline). The depth of sedation was estimated at 5-10-min intervals during the first hour after injection. A comprehensive battery of psychomotor tests was used to collect objective data of psychomotor performance before drug injection and 1, 3, 5, and 7 h after injection. Midazolam (0.15 mg/kg) produced the highest scores of sedation and most impairment of psychomotor performance. In most tests, the maximal psychomotor effects seen after 0.3 mg/kg of diazepam did not reach those of 0.1 mg/kg of midazolam. Although the strongest psychomotor effects were induced by midazolam, these effects disappeared sooner than those of diazepam. By 5 h after injection, 0.3 mg/kg of diazepam showed the highest scores of psychomotor impairment. The authors conclude that at least four times as much diazepam as midazolam is needed to produce equally severe psychomotor impairment. That the residual effects of midazolam terminate sooner than those of diazepam probably accounts for the occasional underestimation of the potency of midazolam in clinical practice.
AuthorsE J Nuotto, K T Korttila, J L Lichtor, P L Ostman, G Rupani
JournalAnesthesia and analgesia (Anesth Analg) Vol. 74 Issue 2 Pg. 265-71 (Feb 1992) ISSN: 0003-2999 [Print] United States
PMID1731549 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Diazepam
  • Midazolam
Topics
  • Adult
  • Amnesia (chemically induced)
  • Diazepam (administration & dosage, pharmacology)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Humans
  • Injections, Intravenous
  • Male
  • Midazolam (administration & dosage, pharmacology)
  • Psychomotor Performance (drug effects)
  • Random Allocation
  • Reaction Time (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: